JH
Javier Herrero
Lund University, Asgard Therapeutics, Universidad Autónoma de Madrid, Universidad Complutense de Madrid, University College London Cancer Institute
Research areas: Biochemistry, Genetics and Molecular Biology · Molecular Biology · Genomics and Phylogenetic Studies · Cancer Immunotherapy and Biomarkers · Cancer Genomics and Diagnostics
0000-0001-7313-717X
Employment
-
Lund University Head of Scientific Data Services at SciLifeLab DC2026 - Present
-
Asgard Therapeutics Project Director Bioinformatics2023 - 2025
-
University College London Cancer Institute Head of the Bill Lyons Informatics Centre2014 - 2023
-
The Genome Analysis Centre (TGAC) Comparative Genomics Project Leader2013 - 2014
-
European Bioinformatics Institute Ensembl Coordinator2011 - 2013
-
European Bioinformatics Institute Ensembl Compara Project Leader2007 - 2013
-
European Bioinformatics Institute Ensembl Developer2004 - 2007
-
Centro Nacional de Investigaciones Oncológicas PhD student2000 - 2004
-
GlaxoWellcome PhD student1999 - 2000
-
Universidad Complutense de Madrid Graduate student1998 - 1998
Education
-
Universidad Autonoma de Madrid PhD in Molecular Biology1999 - 2004
-
Universidad Complutense de Madrid MRes Degree in Chemistry (specialised in Biochemistry)1992 - 1997
Projects & Funding
Projects & funding information is unavailable.
Publications (210)
- Figure 1 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors Save
- Figure 2 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors Save
- Figure 3 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors Save
- Figure 4 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors Save
- Figure 5 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors Save
- Table 1 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors Save
- GIMMEcpg: Global Imputation of Mean CpG MEthylation in Real-time Save
- Prospective validation of ORACLE, a clonal expression biomarker associated with survival of patients with lung adenocarcinoma Save
- Co-option of endogenous retroviruses through genetic escape from TRIM28 repression Save
- The Clinicogenomic Landscape of Induction Failure in Childhood and Young Adult T-Cell Acute Lymphoblastic Leukemia Save
- Genomic-transcriptomic evolution in lung cancer and metastasis Save
- The evolution of non-small cell lung cancer metastases in TRACERx Save
- Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA. Save
- Antibodies against endogenous retroviruses promote lung cancer immunotherapy Save
- Body composition and lung cancer-associated cachexia in TRACERx Save
- Evolutionary characterisation of lung adenocarcinoma morphology in TRACERx Save
- Lung Adenocarcinoma Promotion by Air Pollutants Save
- Data from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors Save
- Data from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors Save
- Supplementary Data from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors Save